EASI-75
Sanofi’s Amlitelimab Shows Mixed Phase 3 Results in Eczema Trials, Clouds Blockbuster Hopes but Advances to Regulatory Filings
Sanofi; amlitelimab; Phase 3; eczema; atopic dermatitis; COAST; SHORE; vIGA-AD; EASI-75
Sanofi Phase 3 Eczema Win Falls Short of Analyst Expectations
Sanofi; amlitelimab; phase 3 trial; eczema; atopic dermatitis; analyst expectations; Dupixent; EASI-75; market reaction